Remediating agitation-induced antibody aggregation by eradicating exposed hydrophobic motifs

Rutilio H Clark1, Ramil F Latypov, Cyr De Imus

  • 1a Department of Therapeutic Discovery; Amgen Inc. ; Thousand Oaks , CA USA.

Mabs
|December 9, 2014
PubMed